| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |